Endoglin as a target of antitumor therapy

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2013, Vol 67, Issue 0

Abstract

Blood vascular supply significantly affects progression of tumor growth. Inhibition of endothelial cell proliferation by antiangiogenic drugs should lead to growth arrest of both primary tumors and metastases. During the course of lengthy therapy, endothelial cells may, however, become refractory to the action of antiangiogenic agents. Novel approaches to anticancer treatment should explore the issue of drug resistance shown by endothelial cells. One possible therapeutic solution might be tumor immunotherapy directed against antigens expressed on the surface of endothelial cells which co-form tumor blood vasculature. Such therapy is supposed to break immune tolerance to own antigens and to eliminate tumor blood vessel endothelial cells by activating cytotoxic T lymphocytes. This kind of response can be obtained against endoglin (CD105). Endoglin is overexpressed in proliferating endothelial cells which line tumor blood vessels. Presence of endoglin in solid tumor blood vessels has prognostic value in cancer treatment. CD105 is also expressed by certain cancer cells (prostate, melanoma and Ewing sarcoma). It appears that therapeutic strategies directed against endoglin allow several mechanisms of resistance to antiangiogenic drugs to be omitted. The therapeutic approach that we propose, i.e. a tumor blood vessel-destroying strategy combined with immunotherapy, may become an effective therapeutic tool.

Authors and Affiliations

Magdalena Jarosz, Stanisław Szala

Keywords

Related Articles

Pain, analgesia, and sex

There is a large volume of data regarding sex differences in pain sensitivity and analgesia in both animals and in humans. It is difficult to analyze all the complex observations and find new aims for future studies. The...

Genetical background of intelligence

Intelligence as an ability to reason, think abstractly and adapt effectively to the environment is a subject of research in the field of psychology, neurobiology, and in the last twenty years genetics as well. Genetical...

The cytokines in inflammatory bowel disease

Inflammatory bowel disease includes ulcerative colitis and Crohn’s disease. It is a group of chronic disorders of unknown etiology characterized by inflammation of the gastrointestinal tract. The etiopathogenesis of infl...

Prognostic value of thymidine kinase activity in patients with chronic lymphocytic leukemia

Thymidine kinase (TK) activity is a marker of biological activity that allows the indolent and aggressive forms of chronic lymphocytic leukemia (CLL) to be distinguished. The aims of the study were to determine the relat...

Zachowanie stabilności genetycznej embrionalnych oraz indukowanych pluripotencjalnych komórek macierzystych podczas terapii przeciwnowotworowych

Medycyna regeneracyjna jest szybko rozwijającą się dziedziną, której postęp umożliwia wydłużenie czasu i poprawę jakości życia chorych cierpiących na nieuleczalne dotąd schorzenia. Komórki macierzyste (stem cells, SCs) s...

Download PDF file
  • EP ID EP66861
  • DOI -
  • Views 159
  • Downloads 0

How To Cite

Magdalena Jarosz, Stanisław Szala (2013). Endoglin as a target of antitumor therapy . Advances in Hygiene and Experimental Medicine, 67(0), 79-89. https://europub.co.uk/articles/-A-66861